Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 6 (2023)

Efficacy of Romiplostim in thrombocytopenic dogs

Author(s):
Sunil S Bhagannavar, Balaji N Ambore, Santosh B Swami, Vitthal S Dhaygude, Sameer N Jadhav, Ajit B Mali, Yogesh B Jadhav and Tejas C Shende
Abstract:
A research investigation was carried out at the Veterinary Clinical Complex of KNP College of Veterinary Science, Shirwal, to examine the Signalment and frequency of thrombocytopenia in canines. The study involved the analysis of 20 thrombocytopenic dogs, where a detailed history was obtained and thorough clinical examinations were conducted to gather the necessary data. Dogs with a medical history of symptoms such as nasal bleeding, petechial haemorrhages, hematemesis, melena, fever, enlarged lymph nodes, anaemia, and lethargy underwent screening for thrombocytopenia. The common general observations in thrombocytopenic dogs were anorexia, in appetence, fever, petechial haemorrhages and melena. Affected dogs had significantly decreased platelet count. Administration of the injection romiplostim resulted in an 80% success rate in rapid recovery of platelet count and absence of any adverse effects.
Pages: 3870-3873  |  937 Views  859 Downloads


The Pharma Innovation Journal
How to cite this article:
Sunil S Bhagannavar, Balaji N Ambore, Santosh B Swami, Vitthal S Dhaygude, Sameer N Jadhav, Ajit B Mali, Yogesh B Jadhav, Tejas C Shende. Efficacy of Romiplostim in thrombocytopenic dogs. Pharma Innovation 2023;12(6):3870-3873.

Call for book chapter